by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersApothecary Pharma, LLC

All Warning Letters

Apothecary Pharma, LLC

Warning LetterOpen

Recipient Title President and Chief Pharmacy Officer, Apothecary Pharma, LLC, 1913 Evans Road Cary , NC 27513-2041 United StatesIssued Dec 1, 2025Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations9

Issue DateDec 1, 2025

Product TypeDrugs

StatusOpen

Letter Details

Firm: Apothecary Pharma, LLC
Location: Recipient Title President and Chief Pharmacy Officer, Apothecary Pharma, LLC, 1913 Evans Road Cary , NC 27513-2041 United States
FEI Number: N/A
Country: United States
Issue Date: December 01, 2025
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Compounding Pharmacy/Adulterated Drug Products

Apothecary Pharma, LLC FDA Warning Letter, December 1, 2025